A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India

Background: To assess safety and tolerability of a diphtheria and tetanus toxoid, acellular pertussis, inactivated poliovirus and Haemophilus influenza type B conjugate adsorbed vaccine (DTaP-IPV + Hib), manufactured by Serum Institute of India Pvt. Ltd. (SIIPL)’s, the current first-in-human Phase 1...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hitt Sharma, Kiran Marthak, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Akash Patel, Harish Rao, Sunil Gairola, Umesh Shaligram
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2023-08-01
Saila:	Vaccine: X
Gaiak:	DTaP-IPV+Hib vaccine Phase 1 Clinical trial Safety Tolerability
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2590136223000414
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!